RNAC
Cartesian Therapeutics Inc.
$8.52
+$0.07(+0.83%)
48
Overall
40
Value
54
Tech
52
Quality
Market Cap
$205.43M
Volume
173.66K
52W Range
$5.98 - $20.30
Target Price
$35.29
EPS Estimates Overview
| Current Quarter | $-0.82 | Next Quarter | $-0.87 |
| Current Year | $-2.38 | Next Year | $-3.33 |
| QoQ Growth | -6.1% | YoY Growth | -39.9% |
| 3Y EPS CAGR | -173.1% | Target Price | $35.29 |
| Consensus | Buy | Upside | +314.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.52 | +0.8% | 173.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW